Advicenne Future Growth
Future criteria checks 6/6
Advicenne is forecast to grow earnings and revenue by 118.1% and 28.2% per annum respectively. EPS is expected to grow by 121.4% per annum. Return on equity is forecast to be 371.7% in 3 years.
Key information
118.1%
Earnings growth rate
121.4%
EPS growth rate
Pharmaceuticals earnings growth | 15.7% |
Revenue growth rate | 28.2% |
Future return on equity | 371.7% |
Analyst coverage | Low |
Last updated | 28 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 6 | 22 | 21 | 22 | 2 |
12/31/2024 | 4 | -8 | -10 | -9 | 1 |
12/31/2023 | 3 | -7 | -7 | -6 | N/A |
9/30/2023 | 3 | -9 | -8 | -7 | N/A |
6/30/2023 | 3 | -10 | -8 | -8 | N/A |
3/31/2023 | 3 | -11 | -9 | -8 | N/A |
12/31/2022 | 3 | -11 | -9 | -9 | N/A |
9/30/2022 | 3 | -10 | -9 | -9 | N/A |
6/30/2022 | 4 | -9 | -9 | -9 | N/A |
3/31/2022 | 4 | -11 | -11 | -11 | N/A |
12/31/2021 | 4 | -12 | -13 | -13 | N/A |
9/30/2021 | 4 | -14 | -13 | -13 | N/A |
6/30/2021 | 4 | -15 | -15 | -14 | N/A |
3/31/2021 | 4 | -15 | -14 | -13 | N/A |
12/31/2020 | 3 | -15 | -12 | -12 | N/A |
9/30/2020 | 3 | -15 | -13 | -12 | N/A |
6/30/2020 | 3 | -15 | N/A | N/A | N/A |
3/31/2020 | 2 | -14 | N/A | N/A | N/A |
12/31/2019 | 3 | -14 | -10 | -9 | N/A |
9/30/2019 | 2 | -11 | N/A | N/A | N/A |
6/30/2019 | 2 | -8 | -11 | -11 | N/A |
3/31/2019 | 1 | -6 | -11 | -10 | N/A |
12/31/2018 | 1 | -5 | -10 | -10 | N/A |
9/30/2018 | 2 | -6 | N/A | N/A | N/A |
6/30/2018 | 2 | -7 | -7 | -6 | N/A |
3/31/2018 | 2 | -7 | -6 | -6 | N/A |
12/31/2017 | 3 | -6 | -6 | -6 | N/A |
9/30/2017 | 2 | -5 | N/A | -5 | N/A |
6/30/2017 | 2 | -4 | N/A | -5 | N/A |
3/31/2017 | 2 | -4 | N/A | -3 | N/A |
12/31/2016 | 2 | -4 | N/A | 0 | N/A |
12/31/2015 | 3 | -2 | N/A | N/A | N/A |
12/31/2014 | 2 | -2 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALDVI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
Earnings vs Market: ALDVI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALDVI is expected to become profitable in the next 3 years.
Revenue vs Market: ALDVI's revenue (28.2% per year) is forecast to grow faster than the French market (5.7% per year).
High Growth Revenue: ALDVI's revenue (28.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALDVI's Return on Equity is forecast to be very high in 3 years time (371.7%).